Structure-based design of eugenol analogs as potential estrogen receptor antagonists
Authors:
- Muhammad RadifarMRMuhammad Radifar
- Leonardus Bs KardonoLKLeonardus Bs Kardono
- Muhammad HanafiMHMuhammad Hanafi
- Enade P IstyastonoEIEnade P Istyastono
Open Access
- 1 October 2012
- journal article
- Published by Biomedical Informatics in Bioinformation
- Vol. 8 (19) , 901-906
Abstract
Eugenol is an essential oil mainly found in the buds and leaves of clove (Syzygium aromaticum (L.) Merrill and Perry), which has been reported to have activity on inhibition of cell proliferation and apoptosis induction in human MCF-7 breast cancer cells. This biological activity is correlated to its activity as an estrogen receptor antagonist. In this article, we present the construction and validation of structure-based virtual screening (SBVS) protocols to identify the potent estrogen receptor α (ER) antagonists. The selected protocol, which gave acceptable enrichment factors as a virtual screening protocol, subsequently used to virtually screen eugenol, its analogs and their dimers. Based on the virtual screening results, dimer eugenol of 4-[4-hydroxy-3-(prop-2-en-1- yl)phenyl]-2-(prop-2-en-1-yl)phenol is recommended to be developed further in order to discover novel and potent ER antagonists.Keywords
This publication has 19 references indexed in Scilit:
- Eugenol—From the Remote Maluku Islands to the International Market Place: A Review of a Remarkable and Versatile MoleculeMolecules, 2012
- Living with breast cancer: Iranian women's lived experiencesInternational Nursing Review, 2012
- Induction of apoptosis by eugenol in human breast cancer cells.2011
- Crystal Structure-Based Virtual Screening for Fragment-like Ligands of the Human Histamine H1 ReceptorJournal of Medicinal Chemistry, 2011
- Fragment-Based Approaches and Computer-Aided Drug Discovery2011
- The importance of ARG513 as a hydrogen bond anchor to discover COX-2 inhibitors in a virtual screening campaignBioinformation, 2011
- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast CancerNew England Journal of Medicine, 2009
- Benchmarking Sets for Molecular DockingJournal of Medicinal Chemistry, 2006
- Comprehensive Evaluation of Tamoxifen Sequential Biotransformation by the Human Cytochrome P450 System in Vitro: Prominent Roles for CYP3A and CYP2D6The Journal of Pharmacology and Experimental Therapeutics, 2004
- Estrogen Receptor in a Human Cell Line (MCF-7) from Breast CarcinomaJournal of Biological Chemistry, 1973